{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-21-010080","form_type":"8-K","ticker":"TENX","cik":"0000034956","company_name":"TENAX THERAPEUTICS, INC.","filed_at":"2021-09-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.352033+00:00","generated_at":"2026-06-29T03:57:27.596229+00:00","sec_items":["3.01","5.02"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Tenax Therapeutics loses audit committee independence after director resignation; Nasdaq grants cure period","bullets":["Director James Mitchum resigned from the Board and its Audit and Compensation Committees effective Sept 8, 2021, for personal reasons.","Resignation leaves the Audit Committee below the three independent members required by Nasdaq Listing Rule 5605(c)(2)(A).","Nasdaq granted a cure period ending at the next annual meeting or March 7, 2022, whichever is earlier.","Company has begun searching for a new independent director to serve on the Audit Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-21-010080","json":"https://secwatch.observer/filing/0001654954-21-010080.json","markdown":"https://secwatch.observer/filing/0001654954-21-010080.md","text":"https://secwatch.observer/filing/0001654954-21-010080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/34956/000165495421010080/0001654954-21-010080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/34956/000165495421010080/tenx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T03:57:27.596229+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6429a4b859","claim":"James Mitchum resigned as Director at TENAX THERAPEUTICS, INC..","evidence_excerpt":"On September 8, 2021, James Mitchum notified the Company that he is voluntarily resigning from the Board and its Audit and Compliance Committee and Compensation Committee, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/34956/000165495421010080/0001654954-21-010080-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}